phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagy, A; Radulovic, S; Schally, AV; Szoke, B | 1 |
| Liebow, C; Reilly, C; Schally, AV; Serrano, M | 1 |
| Redding, TW; Schally, AV | 1 |
3 other study(ies) available for phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Pancreatic Neoplasms
| Article | Year |
|---|---|
Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Division; Cell Line; Growth Hormone; Humans; Methotrexate; Mice; Mice, Nude; Neoplasm Transplantation; Octreotide; Organ Size; Pancreatic Neoplasms; Receptors, Neurotransmitter; Receptors, Somatostatin | 1992 |
Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
Topics: Antineoplastic Agents; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; ErbB Receptors; Growth Hormone-Releasing Hormone; Humans; Octreotide; Pancreatic Neoplasms; Phosphoprotein Phosphatases; Phosphorylation; Protein Tyrosine Phosphatases; Somatostatin; Tumor Cells, Cultured | 1989 |
Use of analogs of LH-RH and somatostatin for the treatment of hormone dependent cancers.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Capsules; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Octreotide; Pancreatic Neoplasms; Prostatic Neoplasms; Rats; Somatostatin; Triptorelin Pamoate | 1988 |